Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

FDA approves Avanir's Phase II trial of MDD candidate AVP-786 The US Food and Drug Administration (FDA) has accepted Avanir Pharmaceuticals' investigational new drug (IND) application for a Phase II trial evaluating the safety and efficacy of its next generation compound AVP-786. Production & Manufacturing > Process & Production > News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

CordenPharma agrees to purchase Peptisyntha from Solvay
By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
Production & Manufacturing > Fine & Speciality Chemicals > News
INVISTA, SilicoLife to develop new technologies for bio-derived processes
By PBR Staff Writer
INVISTA and SilicoLife, a computational biology company, have collaborated to develop new technologies that facilitate bio-derived processes for the production of industrial chemicals.
Production & Manufacturing > Fine & Speciality Chemicals > News

Process & Production

La Jolla secures notice of allowance from USPTO for modified Pectin to treat chronic inflammation
By PBR Staff Writer
US-based La Jolla Pharmaceutical has received notice of allowance from the US Patent and Trademark Office (USPTO) for patent application number 14/254,510 covering methods of treating chronic inflammation by intravenous administration of aqueous modified pectin solutions with molecular weights greater than 25 kilodaltons.
Production & Manufacturing > Process & Production > News
Access Pharmaceuticals awarded Japan patent for MuGard and ProctiGard
Access Pharmaceuticals, an emerging biopharmaceutical company, has received notification from the Japan Patent Office that a patent for MuGard and ProctiGard has been granted.
Production & Manufacturing > Process & Production > News

OTC

7-Keto supplement brand sold to InterHealth
Humanetics, a leading researcher, developer and marketer of pharmaceuticals, medical foods and branded nutraceutical ingredients, announced today that it has sold its 7-Keto dietary ingredient brand to InterHealth Nutraceuticals of Benica, CA.
Production & Manufacturing > OTC > News
Axxess Pharma reports increased global sales
Axxess Pharma Inc., a specialty pharmaceutical and nutritional supplements company, through its wholly owned subsidiary, AllStar Health Brands Inc., is pleased to announce sales is continuing to accelerate in the United States, Canada and Australia. Management is now preparing to expand global sales into New Zealand, South Korea and Indonesia.
Production & Manufacturing > OTC > News

Manufacturing

Apricus Biosciences announces launch of topical treatment for erectile dysfunction vitaros in Germany by Hexal
Apricus Biosciences (APRI), a biopharmaceutical company advancing innovative medicines to meet the needs of patients, has announced the launch in Germany of Vitaros, Apricus' novel topical on-demand treatment for erectile dysfunction (ED), by Hexal AG, an affiliate within the Sandoz Division of the Novartis Group of Companies (Sandoz).
Production & Manufacturing > Manufacturing > News
MediciNova releases positive interim results of Phase IIa MN-166 study in opioid dependence
By PBR Staff Writer
US-based biopharmaceutical firm MediciNova has released positive interim results from a Phase IIa clinical trial of MN-166 (ibudilast) in people with opioid dependence.
Production & Manufacturing > Manufacturing > News